Banque Pictet & Cie Sa Abiomed Inc Transaction History

Banque Pictet & Cie Sa

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$242.49 - $301.46 $410,778 - $510,673	-1,694 Reduced 8.08%	19,284 $4.74 Billion
Q2 2022 Aug 08, 2022	SELL	$224.73 - $338.64 $173,941 - $262,107	-774 Reduced 3.56%	20,978 $5.19 Million
Q1 2022 May 04, 2022	SELL	$277.25 - $366.29 $2.52 Million - $3.34 Million	-9,107 Reduced 29.51%	21,752 $7.21 Million
Q4 2021 Feb 02, 2022	BUY	$300.63 - $371.35 $7.77 Million - $9.6 Million	25,858 Added 517.06%	30,859 $11.1 Million
Q3 2021 Nov 10, 2021	BUY	$310.19 - $376.2 $178,049 - $215,938	574 Added 12.97%	5,001 $1.63 Million
Q2 2021 Aug 12, 2021	BUY	$262.71 - $351.17 $54,643 - $73,043	208 Added 4.93%	4,427 $1.38 Million
Q1 2021 May 11, 2021	BUY	$285.92 - $355.13 $1.21 Million - $1.5 Million	4,219 New	4,219 $1.35 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.